Disclosure Of Fair Value Measurement [Text Block]

Biocartis Group NV - Filing #3123162

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
142,480 EUR
210,517 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
526,405 EUR
5,572 EUR
33,897 EUR
33,897 EUR
711,874 EUR
6,862 EUR
220,657 EUR
455,343 EUR
36,824 EUR
220,657 EUR
5,153 EUR
711,874 EUR
6,102 EUR
36,824 EUR
84,480 EUR
5,291 EUR
84,480 EUR
698,027 EUR
392,259 EUR
4,670 EUR
220,668 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.